1. Details of Change | CEO before Change | - |
CEO after Change | Seung Han Baek | |
2. Reasons for Change | Appointment of a new CEO | |
3. Date of Change | 2022-04-18 | |
4. Date Of Board Of Directors Resolution | 2022-04-14 | |
-Attendance of Outside Directors | Present(No.) | 3 |
Absent(No.) | 0 | |
-Attendance of Auditors(members of Audit Committee) | Present | |
5. Other references useful for making investment decisions | ||
- All members of our audit committee are outside directors. | ||
※ Title and date of other disclosure related to this one | - |
Name (Name of Corporation) | Date of Birth (Date of Establishment if Corporation) | Relationship to Largest Shareholder | Number of Shares | Shareholding Ratio(%) | Remarks |
Seung Han Baek | 1972-08-25 | N/A | 0 | 0% | - |
Name (Name of Corporation) | Name of Company | Listing Status | Date of Delisting(In case of delisted one) | Position | hire date | retirement date | Remarks |
Seung Han Baek | BeckmanCoulter Korea | Unlisted | - | Country GM | 2017-03-13 | 2022-04-01 | - |
Seung Han Baek | Danaher Korea | Unlisted | - | Director | 2017-03-13 | 2022-04-01 | - |
Seung Han Baek | Korea Medical Devices Industry Association | Unlisted | - | Director | 2019-04-10 | 2022-04-04 | - |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Classys Inc. published this content on 15 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2022 00:39:05 UTC.